These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 32197638

  • 1. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats.
    Ishiuchi N, Nakashima A, Doi S, Yoshida K, Maeda S, Kanai R, Yamada Y, Ike T, Doi T, Kato Y, Masaki T.
    Stem Cell Res Ther; 2020 Mar 20; 11(1):130. PubMed ID: 32197638
    [Abstract] [Full Text] [Related]

  • 2. Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis.
    Ishiuchi N, Nakashima A, Doi S, Kanai R, Maeda S, Takahashi S, Nagao M, Masaki T.
    Stem Cell Res Ther; 2021 Aug 23; 12(1):472. PubMed ID: 34425892
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
    Lan YW, Choo KB, Chen CM, Hung TH, Chen YB, Hsieh CH, Kuo HP, Chong KY.
    Stem Cell Res Ther; 2015 May 20; 6(1):97. PubMed ID: 25986930
    [Abstract] [Full Text] [Related]

  • 4. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
    Tseng WC, Lee PY, Tsai MT, Chang FP, Chen NJ, Chien CT, Hung SC, Tarng DC.
    Stem Cell Res Ther; 2021 Jun 28; 12(1):367. PubMed ID: 34183058
    [Abstract] [Full Text] [Related]

  • 5. Intravenous Anesthetics Enhance the Ability of Human Bone Marrow-Derived Mesenchymal Stem Cells to Alleviate Hepatic Ischemia-Reperfusion Injury in a Receptor-Dependent Manner.
    Feng J, Yao W, Zhang Y, Xiang AP, Yuan D, Hei Z.
    Cell Physiol Biochem; 2018 Jun 28; 47(2):556-566. PubMed ID: 29794450
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
    Si X, Liu X, Li J, Wu X.
    Int J Clin Exp Pathol; 2015 Jun 28; 8(10):12368-78. PubMed ID: 26722423
    [Abstract] [Full Text] [Related]

  • 7. Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis.
    Kanai R, Nakashima A, Doi S, Kimura T, Yoshida K, Maeda S, Ishiuchi N, Yamada Y, Ike T, Doi T, Kato Y, Masaki T.
    Sci Rep; 2021 Jan 13; 11(1):850. PubMed ID: 33441701
    [Abstract] [Full Text] [Related]

  • 8. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.
    Jang HR, Park JH, Kwon GY, Lee JE, Huh W, Jin HJ, Choi SJ, Oh W, Oh HY, Kim YG.
    Am J Physiol Renal Physiol; 2014 Nov 15; 307(10):F1149-61. PubMed ID: 25143451
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury.
    Cai J, Jiao X, Zhao S, Liang Y, Ning Y, Shi Y, Fang Y, Ding X, Yu X.
    Cytotherapy; 2019 May 15; 21(5):535-545. PubMed ID: 30685215
    [Abstract] [Full Text] [Related]

  • 10. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.
    Du T, Zou X, Cheng J, Wu S, Zhong L, Ju G, Zhu J, Liu G, Zhu Y, Xia S.
    Stem Cell Res Ther; 2013 Jun 04; 4(3):59. PubMed ID: 23734757
    [Abstract] [Full Text] [Related]

  • 11. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E, Han B, Zhang Q, Rao W, Wang Z, Chang C, Zhang Y, Tu C, Li C, Wu D.
    Stem Cell Res Ther; 2020 Aug 03; 11(1):336. PubMed ID: 32746936
    [Abstract] [Full Text] [Related]

  • 12. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR.
    Shock; 2010 Jan 03; 33(1):24-30. PubMed ID: 19996917
    [Abstract] [Full Text] [Related]

  • 13. Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia/reperfusion injury via TRPC6-induced angiogenesis.
    Yang J, Tang L, Zhang F, Yang T, Lu T, Sun K, Sun N, Ren J, Yan M.
    Stem Cell Res Ther; 2021 Nov 22; 12(1):584. PubMed ID: 34809715
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
    Carmona M, Paco-Meza LM, Ortega R, Cañadillas S, Caballero-Villarraso J, Blanco A, Herrera C.
    Pathol Res Pract; 2022 Feb 22; 230():153756. PubMed ID: 35032832
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
    Han KH, Kim AK, Kim MH, Kim DH, Go HN, Kim DI.
    Cell Biol Int; 2016 Jan 22; 40(1):27-35. PubMed ID: 26222206
    [Abstract] [Full Text] [Related]

  • 16. 14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury.
    Tian H, Lu Y, Shah SP, Wang Q, Hong S.
    Stem Cells Dev; 2012 May 01; 21(7):1187-99. PubMed ID: 21846180
    [Abstract] [Full Text] [Related]

  • 17. Mesenchymal stem cells pretreated with interferon-gamma attenuate renal fibrosis by enhancing regulatory T cell induction.
    Kurawaki S, Nakashima A, Ishiuchi N, Kanai R, Maeda S, Sasaki K, Masaki T.
    Sci Rep; 2024 May 04; 14(1):10251. PubMed ID: 38704512
    [Abstract] [Full Text] [Related]

  • 18. Adipose-Derived Mesenchymal Stromal Cells Under Hypoxia: Changes in Extracellular Vesicles Secretion and Improvement of Renal Recovery after Ischemic Injury.
    Collino F, Lopes JA, Corrêa S, Abdelhay E, Takiya CM, Wendt CHC, de Miranda KR, Vieyra A, Lindoso RS.
    Cell Physiol Biochem; 2019 May 04; 52(6):1463-1483. PubMed ID: 31099507
    [Abstract] [Full Text] [Related]

  • 19. Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects.
    Kadono M, Nakashima A, Ishiuchi N, Sasaki K, Miura Y, Maeda S, Fujita A, Sasaki A, Nagamatsu S, Masaki T.
    Stem Cell Res Ther; 2023 Nov 22; 14(1):337. PubMed ID: 37993965
    [Abstract] [Full Text] [Related]

  • 20. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.
    Chang JW, Tsai HL, Chen CW, Yang HW, Yang AH, Yang LY, Wang PS, Ng YY, Lin TL, Lee OK.
    J Cell Mol Med; 2012 Dec 22; 16(12):2935-49. PubMed ID: 22862802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.